Article
In short...
Neurotech news: French biotechnology developer Neurotech S.A. has appointed Bernard Chauvin as chairman of its board and interim chief executive officer. Bernard Davitian, former chief financial officer, will become executive vice president and chief operating officer.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
